Previous 10 | Next 10 |
InMode (INMD): Q4 Non-GAAP EPS of $0.94 beats by $0.19; GAAP EPS of $0.85 beats by $0.18.Revenue of $75.2M (+60.0% Y/Y) beats by $4.43M.Press Release For further details see: InMode EPS beats by $0.19, beats on revenue
InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth PR Newswire YOKNEAM, Israel, Feb. 10, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provi...
InMode (NASDAQ:INMD) is scheduled to announce Q4 earnings results on Wednesday, February 10th, before market open.The consensus EPS Estimate is $0.75 (+63.0% Y/Y) and the consensus Revenue Estimate is $70.77M (+50.6% Y/Y).Over the last 1 year, INMD has beaten EPS estimates 75% of the time and...
[[AEIS]], [[ARCC]], [[BDC]], [[BG]], [[BXMT]], [[CCJ]], [[CDW]], [[CHEF]], [[CIM]], [[CME]], [[CRTO]], [[DBD]], [[EEFT]], [[FLOW]], [[GM]], [[HCSG]], [[INMD]], [[IPG]], [[IQV]], [[KO]], [[PAG]], [[RDWR]], [[TEVA]], [[TMHC]], [[TPB]], [[UAA]]For Seeking Alpha's full earnings season calendar, c...
An economic rebound in 2021 should benefit small-cap companies. Monetary and fiscal policy alignment to boost economic growth. Small-cap stocks can be the high growth cyclicals and outperform after lagging in 2020. A key risk exists if the rollout of vaccines is slow and pushe...
InMode (INMD) announces preliminary 4Q20 and FY20 results, with revenue expected in the range of $74.5M to $75M vs. $63.71M consensus and $205.5M to $206M (prior guided $192M to $195M) vs. $194.59M consensus.Non-GAAP EPS expected in the range of $0.91 to $0.93 vs. $0.62 consensus for Q4, and ...
InMode Expects Record Fourth Quarter and Full Year 2020 Results, Fourth Quarter Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Guidance of $250- $260M Conference call to be held on February 10 at 8:30 a.m. Ea...
InMode to Participate at the 2021 ICR Conference PR Newswire YOKNEAM, Israel , Jan. 11, 2021 /PRNewswire/ -- /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD ), a leading global provider of innovative medical technologies, today announced its participation in t...
InMode Announces Corporate Social Responsibility Strategy PR Newswire YOQNEAM, Israel , Jan. 6, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced it will present a corporate social responsibil...
InMode to Present at the 23rd Annual Needham Growth Conference PR Newswire YOKNEAM, Israel , Jan. 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy , C...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...